India’s Sun Pharma Hunts For Bargains Amidst Financial Crisis

NEW DELHI - India's Sun Pharmaceutical reported a 135 percent jump in second-quarter net profit as it said it was eyeing more acquisition possibilities with the global financial crisis making valuations of generic companies more attractive